文献速递临床试验与 GCP流行病学与生物统计

保守透析策略与需要透析的急性肾损伤患者的肾功能恢复:LIBERATE-D随机临床试验

A Conservative Dialysis Strategy and Kidney Function Recovery in Dialysis-Requiring Acute Kidney Injury: The Liberation From Acute Dialysis (LIBERATE-D) Randomized Clinical Trial.
PubMed 文献 · JAMA · 2026-01-01

这项多中心、非盲、随机优效性试验纳入220例需要透析的急性肾损伤患者,比较保守透析策略(仅在特定代谢或临床指征时透析)与常规透析(每周3次)。出院时肾功能恢复率保守组64% vs 常规组50%,差异13.8%(95%CI 0.8%-26.8%;P=0.04),但预设校正后OR 1.56(95%CI 0.86-2.84;P=0.15)。作者认为需在更大样本中验证。

要点

  • 出院时肾功能恢复率保守组64% vs 常规组50%,未校正差异13.8%(95%CI 0.8%-26.8%;P=0.04)。
  • 预设校正后OR 1.56(95%CI 0.86-2.84;P=0.15),未达统计学显著。
  • 保守组每周透析次数更少(中位1.8 vs 3.1;差异-1.4,95%CI -1.8至-1.0),至第28天无透析天数更多(中位21 vs 5天;差异16天,95%CI 5-27)。

核心结论

  • 在需要透析的急性肾损伤患者中,保守透析策略在未校正分析中使肾功能恢复时间更短、恢复率更高。
  • 鉴于估计效应量的不确定性,作者认为该方法应在更大研究人群中测试。

研究设计与样本

  • 多中心、非盲、随机优效性试验,在美国4个临床中心进行,入组时间为2020年1月23日至2025年3月10日,末次随访日期为2025年6月10日。
  • 纳入基线估算肾小球滤过率大于15 mL/min/1.73 m2、已启动肾脏替代治疗且血流动力学稳定、计划间断血液透析的需透析急性肾损伤患者。
  • 909例患者接受资格评估,221例随机分组,220例接受分配干预。
  • 保守透析策略组仅在满足特定代谢或临床指征时进行透析;常规透析组每周透析3次直至达到尿量或肌酐清除率标准。
  • 主要终点为出院时未校正的肾功能恢复,定义为存活且未接受透析,并至少连续14天无透析(包括出院后)。

主要发现

  • 参与者平均年龄56岁(SD 16岁),220例中148例(67%)为男性,28例(13%)为黑人,133例(60%)为白人。
  • 基线平均估算肾小球滤过率为64.8 mL/min/1.73 m2(SD 30.9 mL/min/1.73 m2),随机分组前启动肾脏替代治疗的中位时间为9天(IQR 5-18.5天)。
  • 出院时肾功能恢复:保守透析组109例中70例(64%)vs 常规透析组109例中55例(50%),差异13.8%(95%CI 0.8%-26.8%;P=0.04);未校正OR 1.76(95%CI 1.02-3.03;P=0.04);预设校正后OR 1.56(95%CI 0.86-2.84;P=0.15)。
  • 每周透析次数:保守透析组中位1.8次(IQR 0-2.6)vs 常规透析组中位3.1次(IQR 2.6-3.5),差异-1.4(95%CI -1.8至-1.0)。
  • 至第28天连续无透析天数:保守透析组中位21天(IQR 0-28)vs 常规透析组中位5天(IQR 0-21),差异16天(95%CI 5-27);透析相关低血压事件保守组69次 vs 常规组97次。

局限性

  • 作者指出,鉴于估计效应量存在不确定性,该方法应在更大研究人群中测试。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: For patients with dialysis-requiring acute kidney injury, persistent need for dialysis is associated with increased morbidity and mortality, high health care use, and poor quality of life. OBJECTIVE: To test the effect of a conservative dialysis strategy on recovery of kidney function. DESIGN, SETTING, AND PARTICIPANTS: This multicenter, unblinded, randomized superiority trial enrolled participants with dialysis-requiring acute kidney injury who had a baseline estimated glomerular filtration rate greater than 15 mL/min/1.73 m2, had already initiated kidney replacement therapy, and were hemodynamically stable, with planned intermittent hemodialysis between January 23, 2020, and March 10, 2025, at 4 clinical sites in the United States. Of 909 patients assessed for eligibility, 221 were randomized and 220 received the allocated intervention. The date of last follow-up was June 10, 2025. INTERVENTION: With the conservative dialysis strategy, participants received dialysis only when specific metabolic or clinical indications were met. Participants in the conventional dialysis group received dialysis 3 times per week until urine output or creatinine clearance criteria were met. MAIN OUTCOMES AND MEASURES: The primary study end point was unadjusted kidney function recovery at hospital discharge, defined as being alive and not receiving dialysis, with at least 14 consecutive days without dialysis (including after discharge). Two prespecified key secondary end points were the number of dialysis sessions per week and the number of dialysis-free days to day 28. RESULTS: The mean age of participants was 56 years (SD, 16 years). A total of 148 of 220 participants (67%) were male, 28 (13%) were Black, and 133 (60%) were White. Mean baseline estimated glomerular filtration rate was 64.8 mL/min/1.73 m2 (SD, 30.9 mL/min/1.73 m2). Participants had started kidney replacement therapy a median of 9 days (IQR, 5-18.5 days) before randomization. In the conservative dialysis intervention group, 70 of 109 participants (64%) achieved kidney function recovery at hospital discharge vs 55 of 109 participants (50%) in the conventional dialysis control group (difference, 13.8% [95% CI, 0.8%-26.8%; P = .04]; unadjusted odds ratio, 1.76 [95% CI, 1.02-3.03; P = .04]; after prespecified adjustment: odds ratio, 1.56 [95% CI, 0.86-2.84; P = .15]). Participants in the conservative dialysis group received fewer dialysis sessions per week (median, 1.8 [IQR, 0-2.6] vs 3.1 [IQR, 2.6-3.5]; difference, -1.4 [95% CI, -1.8 to -1.0]) and recovered earlier (21 [IQR, 0-28] vs 5 [IQR, 0-21] consecutive dialysis-free days to day 28; difference, 16 days [95% CI, 5-27]). Dialysis-associated hypotension occurred less frequently in the conservative dialysis group (69 vs 97 events). CONCLUSIONS AND RELEVANCE: A conservative dialysis strategy in dialysis-requiring acute kidney injury resulted in a shorter time to and higher rates of recovery of kidney function in the unadjusted analysis. Given uncertainty regarding the estimated effect size, this approach should be tested in a larger study population. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04218370.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Liu KD, Siew ED, Tuot DS, et al. A Conservative Dialysis Strategy and Kidney Function Recovery in Dialysis-Requiring Acute Kidney Injury: The Liberation From Acute Dialysis (LIBERATE-D) Randomized Clinical Trial. JAMA. 2026. PMID: 41201895. doi:10.1001/jama.2025.21530

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。